Verzenio Approved for Women with HR+, HER2- Advanced Breast Cancer

This is promising news-full recovery from tumor growth and 28.4 months of non-advancement of disease. Well, good news that if things go awry with #Ibrance #Verzenio seems like a good next measure. I have to say while I cannot fathom the profits of big pharma yet given my benefits from the advances in medical treatments for Stage 4, imagine if more than 3-5% of R&D were spent on saving our lives? If cancer at stage 4 was not a trip to waiting in a lonely cold jail cell on death row? Picture me running my tin cup along the bars of the jail cell!?!
— Read on breastcancer-news.com/2018/02/28/verzenio-approved-hr-postive-her2-negative-advanced-breast-cancer/amp/

❤️love to hear your feedback❤️